Clinical Positron Emission Tomography/Computed Tomography
Although positron emission tomography/computed tomography (PET/CT) underwent rapid growth during the last quarter-century, becoming a new standard-of-care for imaging most cancer types, CT and bone scan remained the gold standard for patients with prostate cancer. This occurred as 2-fluorine-18-fluoro-2-deoxy-d-glucose was perceived to have a limited role owing to low sensitivity in many patients. A resurgence of interest occurred with the use of fluorine-18-sodium-fluoride PET/CT as a replacement for bone scintigraphy, and then choline, fluciclovine, and dihydrotestosterone (DHT) PET/CT as prostate “specific” radiotracers. The last decade, however, has seen a true revolution with the meteoric rise of prostate-specific membrane antigen PET/CT.
Source: PET Clinics - Category: Radiology Authors: David C. Chen, Siyu Huang, James P. Buteau, Raghava Kashyap, Michael S. Hofman Source Type: research
More News: Acidul | Cancer | Cancer & Oncology | CT Scan | Fluoride | PET Scan | Prostate Cancer | Radiology | Sodium | Sodium Fluoride